The APA Handbook of Psychopharmacology provides a comprehensive working knowledge of basic pharmacology and psychopharmacology, examines the utility of pharmacotherapy for addressing different dimensions of human suffering, and highlights the broader professional and social issues surrounding this work in a language that is suitable for a broad readership. This 33-chapter handbook is designed as a library reference that captures the most current research to date on pharmacotherapy strategies for addressing emotional and behavioral conditions, as an informative guide for educators and students to strengthen their understanding of the scientific and professional issues associated with the field of psychopharmacology, and as an invaluable desk reference for both researchers and practicing clinicians. Chapters cover fundamental principles of pharmacology and psychopharmacology; psychopharmacology for the treatment of psychological disorders, substance use disorders, and addiction; and issues pertaining to professional training, policy, and industry. Most chapters include a tool kit of resources, providing recommended references that clinicians can use in practice and as educational and teaching tools to stay abreast of the latest developments on the pharmacological treatments for each disorder.
Suzette M. Evans, PhD, is a psychologist trained in biopsychology at The University of Chicago and in behavioral pharmacology at the Johns Hopkins University School of Medicine. She is currently professor of clinical neuroscience and research scientist VI in the Department of Psychiatry at Columbia University Medical Center and the New York State Psychiatric Institute. She has been a member of the American Psychological Association (APA) and Division 28 (Psychopharmacology and Substance Abuse) since 1992. She served as President of Division 28 in 2007 and served as a member of the APA Board of Convention Affairs from 2011 to 2014. She is also a recent past editor of the APA journal Experimental and Clinical Psychopharmacology (2011–2017).
Dr. Evans has more than 100 publications and 30 years of research experience that span preclinical research with laboratory animals, human laboratory research, and clinical treatment research in substance abuse. Over the past 25 years Dr. Evans has received continuous research funding, primarily from the National Institute on Drug Abuse. Much of her research has used controlled laboratory procedures in humans to examine the acute behavioral and reinforcing effects of drugs of abuse, including alcohol, cannabis and cocaine. Her focus is identifying potential behavioral and neurobiological markers of vulnerability to identify high risk individuals before they transition from casual recreational use to problematic drug use. Several of these factors include stress, impulsivity, and decision making. Moreover, she has been at the forefront of exploring the role of sex as a biological variable. Much of her past and current research focuses on examining potential differences between males and females, including hormonal influences across the menstrual cycle.